Risk of death following application of paclitaxel‐coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta‐analysis of …
Background Several randomized controlled trials (RCT s) have already shown that
paclitaxel‐coated balloons and stents significantly reduce the rates of vessel restenosis and …
paclitaxel‐coated balloons and stents significantly reduce the rates of vessel restenosis and …
[HTML][HTML] Editor's Choice–2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular …
Document Reviewers b, Petr Widimsky, Philippe Kolh, Stefan Agewall, Héctor Bueno,
Antonio Coca, Gert J. De Borst, Victoria Delgado, Florian Dick, Cetin Erol, Marc Ferrini …
Antonio Coca, Gert J. De Borst, Victoria Delgado, Florian Dick, Cetin Erol, Marc Ferrini …
[PDF][PDF] 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
W 2011 roku ESC opublikowało pierwsze wytyczne dotyczące rozpoznawania i leczenia
chorób tętnic obwodowych (PAD)[1]. Ta publikacja wypełniła ważną lukę wśród wytycznych …
chorób tętnic obwodowych (PAD)[1]. Ta publikacja wypełniła ważną lukę wśród wytycznych …
[HTML][HTML] Trial of a paclitaxel-coated balloon for femoropopliteal artery disease
Background The treatment of peripheral artery disease with percutaneous transluminal
angioplasty is limited by the occurrence of vessel recoil and restenosis. Drug-coated …
angioplasty is limited by the occurrence of vessel recoil and restenosis. Drug-coated …
An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the Inter-Society …
TASC Steering Committee*, MR Jaff… - Journal of …, 2015 - journals.sagepub.com
The Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC)
guidelines were last updated in 2007 (TASC II) and represented the collaboration of …
guidelines were last updated in 2007 (TASC II) and represented the collaboration of …
Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month …
G Tepe, J Laird, P Schneider, M Brodmann… - Circulation, 2015 - Am Heart Assoc
Background—Drug-coated balloons (DCBs) have shown promise in improving the
outcomes for patients with peripheral artery disease. We compared a paclitaxel-coated …
outcomes for patients with peripheral artery disease. We compared a paclitaxel-coated …
Canadian Cardiovascular Society 2022 guidelines for peripheral arterial disease
BL Abramson, M Al-Omran, SS Anand… - Canadian Journal of …, 2022 - Elsevier
Patients with widespread atherosclerosis such as peripheral artery disease (PAD) have a
high risk of cardiovascular and limb symptoms and complications, which affects their quality …
high risk of cardiovascular and limb symptoms and complications, which affects their quality …
Multifaceted role of phyto-derived polyphenols in nanodrug delivery systems
As naturally occurring bioactive products, several lines of evidence have shown the potential
of polyphenols in the medical intervention of various diseases, including tumors …
of polyphenols in the medical intervention of various diseases, including tumors …
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral …
… by: the European Stroke Organisation (ESO … - European heart …, 2011 - academic.oup.com
Cardiovascular diseases (CVDs) are the leading cause of death and disability in Europe,
posing a great social and economic burden. Coronary artery disease (CAD) is the cause of …
posing a great social and economic burden. Coronary artery disease (CAD) is the cause of …
[HTML][HTML] Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and …
Peripheral arterial disease (PAD) continues to grow in global prevalence and consumes an
increasing amount of resources in the United States health care system. Overall rates of …
increasing amount of resources in the United States health care system. Overall rates of …